Is SER (SER) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1.6% / 30% | 22.3% / 30% | 0.0% / 30% | 11369.64% / 5% | ✗ NOT HALAL |
| DJIM | 1.6% / 33% | 22.3% / 33% | 0.0% / 33% | 11369.64% / 5% | ✗ NOT HALAL |
| MSCI | 4.0% / 33% | 54.6% / 33% | 0.0% / 33% | 11369.64% / 5% | ✗ NOT HALAL |
| S&P | 1.6% / 33% | 22.3% / 33% | 0.0% / 33% | 11369.64% / 5% | ✗ NOT HALAL |
| FTSE | 4.0% / 33% | 54.6% / 33% | 0.0% / 50% | 11369.64% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | -18478.5% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -8159.2% | |
| Return on Assets (ROA) | -219.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$17M |
| Free Cash Flow | -$17M |
| Total Debt | $268,000 |
| Current Ratio | 1.7 |
| Total Assets | $7M |
Price & Trading
| Last Close | $2.61 |
| 50-Day MA | $2.18 |
| 200-Day MA | $4.03 |
| Avg Volume | 4.4M |
|
52-Week Range
$1.22
| |
About SER (SER)
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is SER (SER) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), SER is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is SER's debt ratio?
SER's debt ratio is 1.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 4.0%.
What are SER's key financial metrics?
SER has a market capitalization of $28M, and revenue of $56,000. Return on equity stands at -8159.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.